Oncologix Tech Inc. booked $3.7M in FY2014 revenue, growing 1406% year over year — faster than 98% of Financial Services companies we track, at a -35.7% net margin.
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.